$VRTX Vertex Pharmaceuticals Q3 EPS $2.64 Beats $2.32 Estimate, Sales $1.54B Beat $1.47B Estimate Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $2.64 per share which beat the analyst consensus estimate of $2.32 by 13.79 percent. This is a 114.63 percent increase over earnings of $1.23 per share from the same period last year. The company reported quarterly sales of $1.54 billion which beat the analyst consensus estimate of $1.47 billion by 4.49 percent. This is a 61.71 percent increase over sales of $949.83 million the same period last year.